Allan S. Lawrie

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 157 publications

Grounding Language Models in Behavioral Science to Scale Physical Activity Interventions for Hispanic/Latinx Populations.

Grounding Language Models in Behavioral Science to Scale Physical Activity Interventions for Hispanic/Latinx Populations.

Journal: medRxiv : the preprint server for health sciences
Published: June 05, 2026

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

Journal: Science translational medicine
Published: May 20, 2026

Predictive Power of Pulmonary Artery Stiffness - Right Ventricular Interplay, but not Pulmonary Vascular Resistance, in Mild Pulmonary Hypertension: A PVRI GoDeep meta-registry analysis.

Predictive Power of Pulmonary Artery Stiffness - Right Ventricular Interplay, but not Pulmonary Vascular Resistance, in Mild Pulmonary Hypertension: A PVRI GoDeep meta-registry analysis.

Journal: Chest
Published: March 26, 2026

Design and Rationale of the My Heart Counts Cardiovascular Health Study: a Large-Scale, Fully Digital Biobank, and Randomized Trial of Large Language Model-Driven Coaching of Physical Activity.

Design and Rationale of the My Heart Counts Cardiovascular Health Study: a Large-Scale, Fully Digital Biobank, and Randomized Trial of Large Language Model-Driven Coaching of Physical Activity.

Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026

Design and rationale of the my heart counts cardiovascular health study: a large-scale, fully digital biobank, and randomized trial of large language model-driven coaching of physical activity.

Design and rationale of the my heart counts cardiovascular health study: a large-scale, fully digital biobank, and randomized trial of large language model-driven coaching of physical activity.

Journal: American journal of preventive cardiology
Published: March 02, 2026

A blood biomarker to specifically identify idiopathic pulmonary arterial hypertension.

A blood biomarker to specifically identify idiopathic pulmonary arterial hypertension.

Journal: Nature cardiovascular research
Published: February 26, 2026

Revisiting prostaglandin biology in pulmonary arterial hypertension: targeting the EP4/ANXA2 axis.

Revisiting prostaglandin biology in pulmonary arterial hypertension: targeting the EP4/ANXA2 axis.

Journal: European heart journal
Published: November 19, 2025

Vascular smooth muscle cell-derived osteoprotegerin drives pulmonary arterial hypertension via AKT activation and is attenuated by monoclonal antibody therapy.

Vascular smooth muscle cell-derived osteoprotegerin drives pulmonary arterial hypertension via AKT activation and is attenuated by monoclonal antibody therapy.

Journal: Cardiovascular research
Published: October 09, 2025

Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension.

Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension.

Journal: NPJ cardiovascular health
Published: October 02, 2025

Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study.

Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study.

Journal: Pulmonary circulation
Published: September 02, 2025

Assessing pulmonary artery stiffening with ultrasonography: a step forward for the assessment of pulmonary hypertension due to left heart disease?

Assessing pulmonary artery stiffening with ultrasonography: a step forward for the assessment of pulmonary hypertension due to left heart disease?

Journal: Cardiovascular research
Published: July 04, 2025

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment.

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment.

Journal: EBioMedicine
Published: June 21, 2025
Showing 1-12 of 157

Last Updated: 09/26/2026